1965
DOI: 10.1016/s0022-3476(65)80213-x
|View full text |Cite
|
Sign up to set email alerts
|

Hypocomplementemic and normocomplementemic persistent (chronic) glomerulonephritis; clinical and pathologic characteristics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
65
0
1

Year Published

1970
1970
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 206 publications
(69 citation statements)
references
References 0 publications
3
65
0
1
Order By: Relevance
“…The presence of C3NeF in detectable amounts in both patients suggest that C3LyNeF, formed by the reaction of C3NeF and cofactor, was responsible for the low Dr. Vallota is a Fellow of the National Kidney Foundation. INTRODUCTION Membrano-proliferative glomerulonephritis, also designated progressive or hypocomplementemic persistent glomerulonephritis, is characterized by distinctive changes in glomerular morphology and, usually in children, by a marked and prolonged hypocomplementemia (1)(2)(3). Labeled antibody studies show that glomerular-bound C3 is consistently present and at times Clq and IgG can be demonstrated (4).…”
mentioning
confidence: 99%
“…The presence of C3NeF in detectable amounts in both patients suggest that C3LyNeF, formed by the reaction of C3NeF and cofactor, was responsible for the low Dr. Vallota is a Fellow of the National Kidney Foundation. INTRODUCTION Membrano-proliferative glomerulonephritis, also designated progressive or hypocomplementemic persistent glomerulonephritis, is characterized by distinctive changes in glomerular morphology and, usually in children, by a marked and prolonged hypocomplementemia (1)(2)(3). Labeled antibody studies show that glomerular-bound C3 is consistently present and at times Clq and IgG can be demonstrated (4).…”
mentioning
confidence: 99%
“…Second, primary MPGN usually shows low serum C3 associated with predominant C3 deposition. Hypocomplementemia is considered to be present in about 50% of cases at the initial onset time and 80-95% during the course (West et al 1965;Habib et al 1973;Iitaka et al 1995), whereas these patients showed no hypocomplementemia during the entire period. In the present patient, the lack of hypocomplementemia, intensive IgA as well as IgG deposition, and favorable prognosis do not positively support the diagnosis of MPGN.…”
Section: Discussionmentioning
confidence: 99%
“…This network linked investigators in the United States and Europe and conducted remarkably informative studies of the value of renal biopsy as a tool and the correlation of biopsy findings with treatment and prognosis (18,29,30). The use of light microscopy, immunofluorescence, and electron microscopy techniques by the ISKDC and other groups permitted the clinicopathologic identification of several important renal disorders including membranoproliferative glomerulonephritis (31,32), IgA nephropathy (Berger disease) (33), and membranous nephropathy (34).…”
Section: Emergence Of Pediatric Nephrology As a Distinct Disciplimentioning
confidence: 99%
“…Later, Boston Children's Hospital became another important training site. These centers, respectively, focused on animal models of glomerular disease, extremely wellconducted clinicopathologic studies in children, and a fundamental immunologic approach to understanding glomerulonephritis including the role of complement pathway consumption and T cell and B cell function (17,32,35). The physiologic approach, first espoused by Homer Smith, was the mode of operation at Albert Einstein, Buffalo, Georgetown, University of California -San Francisco, and University of TexasGalveston.…”
Section: Development Of Training Programs: 1970 -1980mentioning
confidence: 99%